CRISPR Therapeutics AG (CRSP) Tax Rate (2015 - 2026)
CRISPR Therapeutics AG (CRSP) posted Tax Rate of 0.69% for Q1 2026, down 497.46% sequentially from 0.17% in Q4 2025, and up 13.0% YoY from 0.61% in Q1 2025.
CRISPR Therapeutics AG (CRSP) Tax Rate (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has reported Tax Rate for 12 years, with the latest figure at 0.69% in Q1 2026.
- Quarterly Tax Rate rose 13.0% year-over-year to 0.69% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.41% (down 1831.0% YoY) and the FY2025 annual result came in at 0.45%, down 914.0% from the prior year.
- Tax Rate eased to 0.69% in Q1 2026 per CRSP's latest filing, from 0.17% in the prior quarter.
- Over five years, Tax Rate peaked at 7.89% in Q4 2022 and troughed at 3.39% in Q2 2022.
- A 5-year average of 0.36% and a median of 0.62% in 2024 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2022 and 2023: Tax Rate surged 632 bps in 2022, then tumbled 768 bps in 2023.
- Over 5 years, Tax Rate stood at 7.89% in 2022, then plunged by 97 bps to 0.21% in 2023, then declined by 9 bps to 0.19% in 2024, then retreated by 9 bps to 0.17% in 2025, then sank by 497 bps to 0.69% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 0.69%, 0.17%, and 0.58% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | -1.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.11% |
| Jun 30, 2026 | -1.11% |
| Jun 30, 2026 | -1.11% |
| Mar 31, 2026 | -0.69% |
| Mar 31, 2026 | -0.69% |
| Mar 31, 2026 | -0.69% |
| Dec 31, 2025 | 0.17% |
| Dec 31, 2025 | 0.17% |
| Dec 31, 2025 | 0.17% |
| Sep 30, 2025 | -0.58% |
| Sep 30, 2025 | -0.58% |
| Sep 30, 2025 | -0.58% |
| Jun 30, 2025 | -0.62% |
| Jun 30, 2025 | -0.62% |
| Jun 30, 2025 | -0.62% |
| Mar 31, 2025 | -0.82% |
| Mar 31, 2025 | -0.82% |
| Mar 31, 2025 | -0.82% |
| Dec 31, 2024 | 0.19% |
| Dec 31, 2024 | 0.19% |